Disc Medicine

Forma Therapeutics

This company develops medicines for patients with sickle cell disease and rare blood disorders.

Imara

This biopharmaceutical company develops oral small-molecule therapies to treat patients with rare genetic blood disorders, including sickle cell disease and beta thalassemia.

Velorum Therapeutics

This company develops heme-sequestering biologic drugs for patients with lung cancer, rare genetic porphyrias and heme-induced tissue injuries.

Forma

This company develops small molecule therapies for patients with sickle cell disease and cancer.

Beam Therapeutics

The company develops precision genetic medicines using base editing technology to treat patients with serious genetic diseases such as sickle cell disease.

EDITAS Medicine

The company develops CRISPR-based genome editing medicines to treat patients with serious genetic diseases, including blood disorders and inherited eye conditions.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Shield Therapeutics

This pharmaceutical company develops and commercialises oral iron treatments for adult and adolescent patients with iron deficiency and anaemia.